(GNHAY) – FDA
-
Cara Therapeutics (CARA), Vifor Pharma Announce FDA Approval of KORSUVA
-
Vifor Pharma and Cara Therapeutics (CARA) announce U.S. FDA acceptance and Priority Review of NDA for KORSUVA injection in hemodialysis patients with moderate-to-severe pruritus
-
Back to GNHAY Stock Lookup